We came across a bullish thesis on argenx SE on Lux Opes Research’s Substack. In this article, we will summarize the bulls’ thesis on ARGX. argenx SE’s share was trading at $833.16 as of January 26th. ARGX’s trailing and forward P/E were 35.64 and 27.93 respectively according to Yahoo Finance.
Copyright: nexusplexus / 123RF Stock Photo
argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the...
